Pricing & Access· June 24, 2026 · 26 min read
Pfizer Portfolio Dossier: Patent Cliffs, Shortages, and Recalls
By Ran Chen#Orange Book#Purple Book#FDA Approval
Topic
Manufacturing Capacity
Drug substance, fill-finish, CDMO bottlenecks, inspections, tech transfer, and capacity as a commercial constraint.
Generics· June 21, 2026 · 5 min read
Generic Contrast Media: Amneal's Iohexol CGT Exclusivity and Shortage Triage
By Ran Chen#Generics#Orange Book#Manufacturing Capacity
Manufacturing· June 15, 2026 · 11 min read
ADHD stimulant shortage: 222 records, 75 not fully available, 3-year median age
Manufacturing· June 14, 2026 · 10 min read
Anesthesia injectable shortage: 342 records, 99 not fully available, 8-year median
Manufacturing· June 14, 2026 · 11 min read
The oncology injectable shortage, in data: carboplatin and 18 chemo molecules
Policy· June 13, 2026 · 17 min read
FDA drug recall lookup: reading a Class I/II/III notice and pharmacy triage
Manufacturing· June 13, 2026 · 14 min read
FDA drug shortage list: reading status, reason, and presentation fields
Policy· June 11, 2026 · 12 min read
US drug product landscape: 135,667 NDCs, 49,681 generics, and a 2033 format overhaul
By Ran Chen#FDA Approval#Drug Pricing#Supply Chain
Policy· June 10, 2026 · 9 min read
Drug recalls by the numbers: 17,683 events, 80% Class II, and a sterility crisis
Approvals· June 10, 2026 · 10 min read
The FDA approval engine: 29,135 applications, 78% generics, and a BLA surge
By Ran Chen#FDA Approval#Generic Entry#Biosimilars